Press Releases on June 5, 2023 - EIN Presswire - Press Release Distribution Service

Published on June 5, 2023 - 12:00 GMT

Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial Under Investigation for the ...

The Phase 1/2 REVEAL trial is a first-in-human, randomized, dose-escalation and dose-expansion study evaluating the safety and preliminary efficacy of TSHA-102 in adults with Rett syndrome TSHA-102 utilizes novel miRARE technology, designed to regulate …

Distribution channels: Technology ...

Published on June 5, 2023 - 12:00 GMT

Utility Broadband Initiatives in Arkansas and Mississippi Leverage DZS and Irby Expertise to Each Accelerate Past 12,000 ...

DALLAS, June 05, 2023 (GLOBE NEWSWIRE) -- DZS (Nasdaq: DZSI), a global leader of access, optical and cloud-controlled software defined solutions, and its strategic partner Irby Utilities (Irby) today announced deployment milestones reached by two of their …

Distribution channels: Media, Advertising & PR ...

Published on June 5, 2023 - 12:00 GMT

A-Mark Precious Metals Increases Share Repurchase Program and Extends Expiration Date

EL SEGUNDO, Calif., June 05, 2023 (GLOBE NEWSWIRE) -- The board of directors of A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated precious metals platform, has authorized an increase in the number of shares which may be …

Distribution channels: Mining Industry ...

Published on June 5, 2023 - 12:00 GMT

Apollo Funds to Invest $2 Billion in Preferred Equity of AT&T Mobility II LLC

NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that, on behalf of its affiliated and third-party insurance clients and other investors, it has agreed to invest $2.0 billion in preferred equity securities to be issued by AT…

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on June 5, 2023 - 12:00 GMT

Inspire Medical Systems, Inc. Announces Events at SLEEP 2023, the 37th Annual Meeting of the Associated Professional Sleep ...

MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on June 5, 2023 - 12:00 GMT

WSP Completes the Acquisition of Calibre

MONTREAL, June 05, 2023 (GLOBE NEWSWIRE) -- WSP Global Inc. (TSX: WSP) (“WSP” or the “Corporation”) is pleased to announce that it has completed the acquisition of Calibre Professional Services One Pty Ltd (“Calibre”), in Australia. With the addition of …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on June 5, 2023 - 12:00 GMT

WSP complète l’acquisition de Calibre

MONTRÉAL, 05 juin 2023 (GLOBE NEWSWIRE) -- Groupe WSP Global Inc. (TSX : WSP) (« WSP » ou la « Société ») a le plaisir d’annoncer la clôture de l’acquisition de Calibre Professional Services One Pty Ltd (« Calibre »), en Australie. Avec l’ajout des 800 …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on June 5, 2023 - 12:00 GMT

Immutep Reports Final Positive Data in 2nd Line Head and Neck Squamous Cell Carcinoma at ASCO 2023 Annual Meeting

Media Release Efti plus pembrolizumab led to deep, durable responses, regardless of PD-L1 expression levels, and median Duration of Response not reached despite median follow up of 39 months in TACTI-002 Phase II Promising efficacy in patients with a PD-L1 …

Distribution channels: Technology ...

Published on June 5, 2023 - 12:00 GMT

Imbria Pharmaceuticals Completes Enrollment in Phase 2 IMPROVE-HCM Trial of Ninerafaxstat in Patients with Non-obstructive ...

– Enrollment exceeded expectations, thus highlighting the large unmet need in non-obstructive hypertrophic cardiomyopathy – – IMPROVE-HCM topline data expected in 4Q 2023 – – Topline Phase 2 data from the IMPROVE-ISCHEMIA clinical trial in Stable Angina …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 5, 2023 - 12:00 GMT

Revolo Biotherapeutics Presents New Data for ‘1805 in Inflammatory Bowel Disease and Rheumatoid Arthritis at the 5th Treg Directed ...

NEW ORLEANS and CAMBRIDGE, United Kingdom, June 05, 2023 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on June 5, 2023 - 12:00 GMT

Updated RINGSIDE Phase 2 Results Featured in Poster Discussion Session at 2023 American Society of Clinical Oncology (ASCO) Annual ...

Data show enhanced anti-tumor activity of AL102 over time Registration-enabling Phase 3 segment of RINGSIDE is enrolling patients globally Company to host conference call and webcast to discuss updated Phase 2 results on Wednesday, June 7 REHOVOT, Israel …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on June 5, 2023 - 12:00 GMT

Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced ...

Interim data presented at ASCO show early evidence of single agent activity with meaningful reduction of several target lesions Based on the favorable safety and tolerability data at all doses tested to date, the Company intends to expand Phase 1 portion …

Distribution channels: Technology ...

Published on June 5, 2023 - 12:00 GMT

Daré Bioscience Announces Positive Topline Data from the Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women ...

Sildenafil Cream-treated patients showed meaningful improvement in the co-primary endpoint assessment that evaluated change from baseline in the Arousal-Sensation Domain of the Sexual Function Questionnaire Sildenafil Cream-treated patients also showed …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 5, 2023 - 12:00 GMT

Erayak Power Solution Group Inc. to Present at the Virtual BetterInvesting National Convention

Wenzhou, China, June 05, 2023 (GLOBE NEWSWIRE) -- Erayak Power Solution Group Inc. ("Erayak" or the "Company") (Nasdaq: RAYA), a leading manufacturer, designer, and exporter of high-quality products in the power supply industry, is …

Distribution channels: Energy Industry, Environment ...

Published on June 5, 2023 - 12:00 GMT

Osisko Publishes 2023 Asset Handbook Along With 2022 Sustainability Report

MONTRÉAL, June 05, 2023 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (OR: TSX & NYSE) is pleased to announce the publication of its annual Asset Handbook and the third edition of the Corporation’s Sustainability Report, …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on June 5, 2023 - 12:00 GMT

Carina Biotech Appoints Two New U.S. Based Biotechnology Executives to the Board of Directors

ADELAIDE, Australia, June 05, 2023 (GLOBE NEWSWIRE) -- Carina Biotech (Carina), a cell therapy immuno-oncology company, today announced the appointment of Michael S. Wyzga, M.B.A., and Remus Vezan M.D., Ph.D., to its Board of Directors. Mr. Wyzga is an …

Distribution channels: Companies, Technology ...

Published on June 5, 2023 - 12:00 GMT

Osisko publie son recueil d’actifs 2023 ainsi que le rapport de développement durable 2022

MONTRÉAL, 05 juin 2023 (GLOBE NEWSWIRE) -- Redevances Aurifères Osisko Ltée (la « Société » ou « Osisko ») (TSX et NYSE : OR) a le plaisir d’annoncer la publication de son recueil d’actifs annuel et de la troisième édition du rapport sur le développement …

Distribution channels: Media, Advertising & PR, Mining Industry ...

Published on June 5, 2023 - 12:00 GMT

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE …

Distribution channels: Media, Advertising & PR, Technology ...

Published on June 5, 2023 - 12:00 GMT

Blackford Capital Acquires Industrial Automation Leader PACIV

GRAND RAPIDS, Mich., June 05, 2023 (GLOBE NEWSWIRE) -- Blackford Capital (“Blackford”), a leading lower middle market private equity firm, announced today the acquisition of PACIV which specializes in industrial automation solutions. PACIV is a leading …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on June 5, 2023 - 12:00 GMT

NowVertical Group Announces Sasha Grujicic as CEO, Board Appointments and Participation in TSX Technology Investor Day

TORONTO, June 05, 2023 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSX-V: NOW) (OTCQB: NOWVF) (the “Company”), a global big data analytics software and services company, further to its release on May 30, 2023, is pleased to announce that the Company has …

Distribution channels: Companies, Culture, Society & Lifestyle ...